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Reproductive factors influence the risk of cancers of the female
genital tract (uterus and ovary) and breast. The following
reproductive factors are important in this respect: age at
menarche; age at first birth; parity; age at menopause; and
duration of breastfeeding. The effects of exogenous hormones are
described in Section 10.
Age at menarche
Early age at menarche has been consistently associated with an
increased risk of breast and endometrial cancer (Pike et al, 2004).
Relative risk (RR) for premenopausal breast cancer is reduced
by an estimated 7% for each year that menarche is delayed after
age 12 years, and by 3% for post-menopausal breast cancer
(Clavel-Chapelon, 2002). The effect on risk is through prolongation
of the period with relatively high exposure to endogenous
oestrogen.
Age at first birth
The younger the woman is when she begins childbearing, the lower
her risk of breast cancer (Kelsey et al, 1993). The RR of developing
breast cancer increases by 3% for each year of delay (Collaborative
Group, 2002).
Parity
Increasing parity reduces the risk of breast, endometrial and
ovarian cancers (Pike et al, 2004). The higher the number of full-
term pregnancies, the greater the protection. Compared with
nulliparous women, a woman who has at least one full-term
pregnancy reduces her risk of breast cancer by around 25% (Layde
et al, 1989; Ewertz et al, 1990) and women with five or more
children experience a 50% reduction in risk (Kelsey et al, 1993).
For endometrial cancer, risk is reduced by 30% for a woman’s first
birth and by 25% for each successive birth, and later maternal age
at last birth has also been shown to reduce the risk (Pike et al,
2004). For ovarian cancer, risk in women with four pregnancies is
only 40% that in nulliparous women (Ness et al, 2002). However,
increasing parity increases the risk of cancer of the cervix,
independently of any increase in the prevalence of infection with
HPV (Munoz et al, 2002).
Age at menopause
Late menopause increases the risk of breast cancer and
endometrial cancer (Pike et al, 2004). For breast cancer, risk is
doubled for a woman with menopause at 55 years compared
with less than 45 years (Kelsey et al, 1993). For each year that
the menopause is delayed, there is an approximate 3% increase
in breast cancer risk (Collaborative Group, 1997). Postmeno-
pausal women have a lower risk of breast cancer compared
with premenopausal women of the same age, both for natural
menopause and for menopause induced through surgery
(Collaborative Group, 1997).
Breastfeeding
The role of breastfeeding as a protective factor against the later
development of breast cancer has been long suspected (Lane-
Claypon, 1926). More recently, this association has been confirmed
and the magnitude of the effect estimated as a decrease in risk of
4.3% for every 12 months of breastfeeding (Collaborative Group
on Hormonal Factors in Breast Cancer, 2002). For ovarian cancer,
the issue is less clear. An early collaborative analysis of case–
control studies found a reduced risk in parous women who had
ever breastfed compared with those who had never done so
(Whittemore et al, 1992). Subsequent work suggested that only
serous tumours may be so influenced (Jordan et al, 2007, 2008).
A recent analysis of two US cohort studies (Danforth et al, 2007)
suggests that each month of breastfeeding reduces the RR by 2%
(RR¼0.98 per month, 95% CI 0.97–1.00).
Although a woman’s reproductive behaviour can influence
the risk of cancers of the uterus, ovary and breast, most of
the important aspects discussed above are not sensibly considered
as targets for preventive interventions.
In this section, therefore, only the cancers attributable to sub-
optimal levels of breastfeeding are evaluated.
METHODS
Breastfeeding of infants in Britain is not very common, and is
generally not prolonged for more than a few weeks. Surveys of
infant feeding in the UK, at 5-yearly intervals since 1975, have been
carried out by the Department of Health. The most recent survey
(the seventh) was in 2005 (Bolling et al, 2007). Table 1 shows the
results of these surveys. *Correspondence: Professor DM Parkin; E-mail: d.m.parkin@qmul.ac.uk
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relatively secure, as the decline in breastfeeding prevalence with
time since birth in women who do actually commence seems to be
relatively constant (Figure 1).
There is no generally accepted target for breastfeeding. The
Global Strategy on Diet, Physical Activity and Health of the World
Health Organisation (WHO, 2004) includes a recommendation to
‘promote and support exclusive breastfeeding for the first six
months of life and promote programmes to ensure optimal feeding
for all infants and young children’. Therefore, we have taken as the
optimum breastfeeding of all live-born children for six months,
with no change to the current pattern after this time. Currently,
some 18% of women are breastfeeding to 9 months of age
(Table 1).
Table 2 gives information on the birth experience of women
in England and Wales in 2008, the most recent year available
(Office for National Statistics, 2009).
Table 3 shows the estimated duration of breastfeeding (based on
the data of Table 1).
With a change in risk for each month of breastfeeding of
 0.366% for breast cancer and  2.0% for ovarian cancer
(Collaborative Group on Hormonal Factors in Breast Cancer,
2002; Danforth et al, 2007), the actual protection provided by the
breastfeeding practices of each generation of women can be
estimated (column 1 of Table 4). The breastfeeding practices from
Table 1 are assumed to apply to the year in which 50% of the
children in a given age group in 2008 would have been born. Since
there are no data on breastfeeding practices prior to 1980, the
duration of having been breastfed for women in the age groups
X55–59 are taken to be the same as in 1980.Table 3 also shows
the estimated mean duration of breastfeeding if all women
could breastfeed their children for 6 months (so that prevalence
at 6 months is 100%), after which the values in Table 1 continue to
pertain.
RESULTS
Column 1 of Table 4 shows the decrease in risk of breast and
ovarian cancer due to breastfeeding, of women in the UK, by age
group, in 2008, and column 2 the decrease in risk if all had been
breastfed for a minimum of 6 months. Column 3 shows the excess
risk of women in 2008, due to their breastfeeding practice being
short of target, and column 4 the population-attributable fraction
of breast and ovarian cancer cases by age.
In Table 5, we assume that the RR estimated for 2008 is
pertinent for 2010, and show the actual numbers of cancer cases
that would be attributable to breastfeeding practices not reaching
the optimum level.
In total 2699 cancer cases projected to occur in 2010 (1498 breast
cancers, 1201 ovarian cancers) would have been avoided if
breastfeeding practice had been at the theoretical ‘optimum’. This
Table 1 Percentage of women breastfeeding at given intervals post
partum (Great Britain)
% Women breastfeeding, by year of survey
Interval post
partum 1980 1985 1990 1995 2000 2005
Birth 65 63 62 66 69 76
1 Week 54 52 51 56 55 63
2 Weeks 51 49 48 53 52 60
6 Weeks 41 39 39 42 42 48
4 Months 27 27 26 27 28 34
6 Months 21 20 20 21 21 25
8 Months 15 14 14 15 16 21
9 Months 14 13 13 14 13 18
Values in italics have been interpolated.
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Figure 1 Percent of women continuing breastfeeding, by time since
birth.
Table 2 Natality of women in England and Wales in 2008, by age/birth
cohort
Age
(years)
Central
birth
year
Average
number
of live-born
children
Average age
when 50%
children had
been born
Average year
when 50%
children had
been born
0–4 2006 0 — —
5–9 2001 0 — —
10–14 1996 0 — —
15–19 1991 0.04 13 2004
20–24 1986 0.34 19 2003
25–29 1981 0.80 23 2001
30–34 1976 1.34 26 1999
35–39 1971 1.75 26 1996
40–44 1966 1.90 26 1991
45–49 1961 1.96 27 1985
50–54 1956 2.02 26 1980
55–59 1951 2.04 25 1974
60–64 1946 2.19 25 1968
65–69 1941 2.34 25 1964
70–74 1936 2.40 26 1960
75–79 1931 2.35 27 1956
80–84 1926 2.12 27 1951
X85 1921 2.00 27 1946
Table 3 Median and mean duration of breast feeding (Great Britain)
Duration of breastfeeding (months)
by year of survey
Average 1980 1985 1990 1995 2000 2005
Median 0.60 0.48 0.38 0.84 0.71 1.46
Mean 2.84 2.75 2.71 2.89 2.90 3.50
Mean if all X6 months
a 6.78 6.75 6.74 6.79 6.78 7.02
aMean if all women could breastfeed their children for 6 months (so prevalence
at 6 months is 100%).
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DISCUSSION
Though it may be desirable, from the point of view of cancer
prevention, to have multiple pregnancies commencing at a young
age, there are equally, or more, persuasive reasons to avoid such a
lifestyle. It makes no sense, therefore, to prescribe an ideal fertility
pattern, against which the number of cancers attributable to a less
optimum one can be evaluated. In the IARC calculation of
avoidable cancers in France (IARC, 2007), the fertility pattern of
1980 was taken as an ideal against which the excess cases resulting
from fertility in 2000 were calculated, although the rationale for
this was not explained. The origin of the Doll and Peto (2003)
estimate of 15% of UK cancer deaths being attributable to
‘reproduction’ (and other factors related to the secretion of
reproductive hormones) is obscure; the methodology is said to be
the same as in their 1981 monograph (Doll and Peto, 1981),
although this considers some 46% of the deaths due to cancers of
the breast, ovary and uterus (corpus and cervix) as attributable to
reproductive and sexual factors, and these cancers are responsible
for only 8% of cancer deaths in UK in 2005.
Table 4 Effect of breastfeeding on women’s risk of breast and ovarian cancer, UK 2008
Breast cancer Ovarian cancer
12 3 4 12 3 4
Age
(years)
Estimated individual
decrease in risk
Target decrease
in risk
a
Excess
risk
PAF
(%)
Estimated individual
decrease in risk
Target decrease
in risk
a
Excess
risk
PAF
(%)
0 – 4 — —0 — — —0 —
5 – 9 — —0 — — —0 —
1 0 – 1 4 — —0 — — —0 —
15–19 0.0005 0.0010 0.001 0.1 0.0026 0.0052 0.003 0.3
20–24 0.0043 0.0086 0.004 0.4 0.0219 0.0443 0.022 2.3
25–29 0.0084 0.0196 0.011 1.1 0.0429 0.1010 0.058 6.1
30–34 0.0140 0.0328 0.019 1.9 0.0718 0.1691 0.097 10.5
35–39 0.0183 0.0429 0.025 2.5 0.0935 0.2212 0.128 14.1
40–44 0.0186 0.0463 0.028 2.8 0.0951 0.2387 0.144 15.9
45–49 0.0195 0.0478 0.028 2.9 0.0997 0.2466 0.147 16.3
50–54 0.0207 0.0495 0.029 2.9 0.1060 0.2550 0.149 16.7
55–59 0.0209 0.0500 0.029 3.0 0.1071 0.2575 0.150 16.8
60–64 0.0225 0.0536 0.031 3.2 0.1149 0.2764 0.161 18.2
65–69 0.0240 0.0573 0.033 3.4 0.1228 0.2953 0.173 19.7
70v74 0.0246 0.0588 0.034 3.5 0.1260 0.3029 0.177 20.2
75–79 0.0241 0.0576 0.033 3.4 0.1233 0.2966 0.173 19.8
80–84 0.0217 0.0519 0.030 3.1 0.1113 0.2676 0.156 17.6
X85 0.0205 0.0490 0.028 2.9 0.1050 0.2524 0.147 16.5
Abbreviation: PAF¼population-attributable fraction.
aIf all had breastfed for a minimum of 6 months.
Table 5 Cases of breast and ovarian cancer estimated to be due to sub-optimal breast feeding, UK 2010
Breast Ovary
Age
(years)
Relative
risk
Observed
cases
Excess attributable
cases
PAF
(%)
Relative
risk
Observed
cases
Excess attributable
cases
PAF
(%)
0–4 1 2 0 — 1 2 0 —
5–9 1 0 0 — 1 4 2 —
10–14 1 0 0 — 1 6 3 —
15–19 1.0005 4 0 0.1 1.0026 23 0 0.3
20–24 1.0044 32 0 0.4 1.0234 57 1 2.3
25–29 1.0114 167 2 1.1 1.0646 90 5 6.1
30–34 1.0194 548 10 1.9 1.1171 103 11 10.5
35–39 1.0258 1265 32 2.5 1.1639 160 23 14.1
40–44 1.0291 2593 73 2.8 1.1885 278 44 15.9
45–49 1.0298 4236 123 2.9 1.1950 428 70 16.3
50–54 1.0303 4810 141 2.9 1.1999 498 83 16.7
55–59 1.0306 5582 166 3.0 1.2026 623 105 16.8
60–64 1.0329 6459 206 3.2 1.2232 883 161 18.2
65–69 1.0353 6403 219 3.4 1.2448 852 168 19.7
70–74 1.0363 4332 152 3.5 1.2538 828 168 20.2
75–79 1.0355 4058 139 3.4 1.2463 734 145 19.8
80–84 1.0318 3526 109 3.1 1.2134 616 108 17.6
X85 1.0299 4367 127 2.9 1.1973 635 105 16.5
All ages 48385 1498 3.1 6820 1201 17.6
Abbreviation: PAF¼population-attributable fraction.
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of reasons, of which the benefit of cancer protection is one (http://
www.breastfeeding.nhs.uk/en/fe/page.asp?n1¼2). The ‘optimum’
levels for breastfeeding against which attributable fractions of
breast and ovarian cancer have been evaluated are rather artificial,
in that it would be impossible for all women to breastfeed
their infant for 6 months. In the United States, for example, the
US Department of Health and Human Services (2005) Healthy
People 2010 objectives for breastfeeding initiation and duration
were to increase the proportion of mothers who exclusively
breastfeed their infants through age 3 months to 60% and through
age 6 months to 25%. Exclusive breastfeeding is defined as an
infant receiving only breast milk and no other liquids or solids
except for drops or syrups consisting of vitamins, minerals or
medicines (WHO, 1991). Clearly, the target for partial breastfeed-
ing may be more ambitious, so that the target may not be so very
far from the theoretical optimum, advocated by WHO.
See acknowledgements on page Si.
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